Not provided
Not provided
Not provided
Not provided
lack of recrutment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a study whose main objective is to evaluate prospectively the proportion of patients with severe xerostomia one year after treatment with tomotherapy for head and neck cancer.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tomotherapy | Radiation | Patients receive radiotherapy by Tomotherapy for 7 weeks at the ENT |
| Measure | Description | Time Frame |
|---|---|---|
| the proportion of patients with xerostomia | Estimate the proportion of patients with xerostomia of grade greater than or equal to 2 assessed by the scale of late toxicity RTOG / EORTC 12 months after completion of radiotherapy. | 12 months after completion of radiotherapy. |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of acute and late xerostomia | Evaluation of acute xerostomia | after 3, 6 and 12 months after radiotherapy |
| Measurement of salivary flow with and without stimulation | Measurement of salivary flow with and without stimulation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| bernard GERY, MD | Centre François Baclesse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre François BACLESSE | Caen | 14076 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| at 3, 6 and 12 months after end of radiotherapy |
| Evaluation of the incidence of acute side effects of radiotherapy | Evaluation of the incidence of acute and late side effects of radiotherapy | Weekly during radiotherapy |
| Evaluation of the incidence of late side effects of radiotherapy | Evaluation of the incidence of late side effects of radiotherapy | At 3, 6 and 12 months after radiotherapy |
| Evaluation of quality of life and fatigue | Evaluation of quality of life and fatigue | At 3, 6 and 12 months after radiotherapy |
| Evaluation of overall survival and progression-free survival | Evaluation of overall survival and progression-free survival | at 3, 6 and 12 months after radiotherapy |
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| D000077195 | Squamous Cell Carcinoma of Head and Neck |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D002294 | Carcinoma, Squamous Cell |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
| ID | Term |
|---|---|
| D050397 | Radiotherapy, Intensity-Modulated |
| ID | Term |
|---|---|
| D020266 | Radiotherapy, Conformal |
| D011881 | Radiotherapy, Computer-Assisted |
| D011878 | Radiotherapy |
| D013812 | Therapeutics |
Not provided
Not provided